Literature DB >> 23633479

Editorial: Leukocytes in tularemia--so many cells, so little time.

Lee-Ann H Allen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23633479      PMCID： PMC3629439          DOI： 10.1189/jlb.1212661

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN： 0741-5400            Impact factor:   4.962


× No keyword cloud information.
  13 in total

Review 1.  Points of control in inflammation.

Authors:  Carl Nathan
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

2.  IFN-β mediates suppression of IL-12p40 in human dendritic cells following infection with virulent Francisella tularensis.

Authors:  Timothy J Bauler; Jennifer C Chase; Catharine M Bosio
Journal:  J Immunol       Date:  2011-07-13       Impact factor: 5.422

Review 3.  Neutrophils in the activation and regulation of innate and adaptive immunity.

Authors:  Alberto Mantovani; Marco A Cassatella; Claudio Costantini; Sébastien Jaillon
Journal:  Nat Rev Immunol       Date:  2011-07-25       Impact factor: 53.106

4.  Development of tolerogenic dendritic cells and regulatory T cells favors exponential bacterial growth and survival during early respiratory tularemia.

Authors:  Sivakumar Periasamy; Anju Singh; Bikash Sahay; Tabassum Rahman; Paul J Feustel; Giang H Pham; Edmund J Gosselin; Timothy J Sellati
Journal:  J Leukoc Biol       Date:  2011-07-01       Impact factor: 4.962

5.  IL-12Rβ2 is critical for survival of primary Francisella tularensis LVS infection.

Authors:  Amanda A Melillo; Oded Foreman; Karen L Elkins
Journal:  J Leukoc Biol       Date:  2013-02-25       Impact factor: 4.962

Review 6.  Anti-p40 antibodies ustekinumab and briakinumab: blockade of interleukin-12 and interleukin-23 in the treatment of psoriasis.

Authors:  Mona Gandhi; Eihab Alwawi; Kenneth B Gordon
Journal:  Semin Cutan Med Surg       Date:  2010-03

7.  Francisella tularensis LVS evades killing by human neutrophils via inhibition of the respiratory burst and phagosome escape.

Authors:  Ramona L McCaffrey; Lee-Ann H Allen
Journal:  J Leukoc Biol       Date:  2006-08-14       Impact factor: 4.962

8.  Francisella tularensis inhibits the intrinsic and extrinsic pathways to delay constitutive apoptosis and prolong human neutrophil lifespan.

Authors:  Justin T Schwartz; Jason H Barker; Justin Kaufman; Drew C Fayram; Jenna M McCracken; Lee-Ann H Allen
Journal:  J Immunol       Date:  2012-02-22       Impact factor: 5.422

9.  Hepatitis B virus reactivation during therapy with ustekinumab for psoriasis in a hepatitis B surface-antigen-negative anti-HBs-positive patient.

Authors:  J Koskinas; M Tampaki; P P Doumba; E Rallis
Journal:  Br J Dermatol       Date:  2013-01-31       Impact factor: 9.302

10.  Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemia.

Authors:  Deborah D Crane; Dana P Scott; Catharine M Bosio
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240
View more
  4 in total

1.  Increased Resistance to Intradermal Francisella tularensis LVS Infection by Inactivation of the Sts Phosphatases.

Authors:  Kaustubh Parashar; Erik Kopping; David Frank; Vinaya Sampath; David G Thanassi; Nick Carpino
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

2.  Francisella tularensis Modulates a Distinct Subset of Regulatory Factors and Sustains Mitochondrial Integrity to Impair Human Neutrophil Apoptosis.

Authors:  Jenna M McCracken; Lauren C Kinkead; Ramona L McCaffrey; Lee-Ann H Allen
Journal:  J Innate Immun       Date:  2016-02-24       Impact factor: 7.349

3.  Differential expression of microRNAs in Francisella tularensis-infected human macrophages: miR-155-dependent downregulation of MyD88 inhibits the inflammatory response.

Authors:  Sarmistha Bandyopadhyay; Matthew E Long; Lee-Ann H Allen
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

4.  An Immature Myeloid/Myeloid-Suppressor Cell Response Associated with Necrotizing Inflammation Mediates Lethal Pulmonary Tularemia.

Authors:  Sivakumar Periasamy; Dorina Avram; Amanda McCabe; Katherine C MacNamara; Timothy J Sellati; Jonathan A Harton
Journal:  PLoS Pathog       Date:  2016-03-25       Impact factor: 6.823
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.